Mental Health DisorderPsyPreDiNCT06489912
Overview of the Mental Health of Adolescents in Therapeutci, Educational and Pedagogical Facilities in France
An observational study of Mental Health Disorder, run by University Hospital, Rouen at 2 sites in France.
Trial summary
Assess the prevalence of various psychiatric disorders in adolescents aged 12 to 16 receiving support from therapeutic, educational and pedagogical institutes. Read more about this study
- Who is it for?
- Ages 12 to 16 yearsHealthy volunteers can take part
- Conditions the study is for
- Mental Health Disorder
- What is being tested?
- WAIS IV
- Type of treatment
- Injection or infusion
- How many people
- 200 participants
- Where
- 2 sitesFrance
- Study dates
- 20 Dec 2024to 31 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 16 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: This is a prospective, multicentric, national cohort, including adolescents aged 12 to 16 consecutively, who have been in a French-speaking, voluntary DITEP for at least 15 days, and whose parents have given their consent. This choice was motivated by the fact that this is the age group most represented in Therapeutic, Educatuional and Pedagogical Institutes
Who may be able to join
- Adolescent aged 12 to 16
- In a DITEP for at least 15 days
- Minor who has been informed and has not objected to the research (according to his/her capacity)
- At least one person exercising parental authority who has read and understood the information note and has not objected to the research OR
- For a minor under guardianship: legal representative who has read and understood the information note and has not objected to the research.
Who cannot join
- Minor and/or person(s) exercising parental authority who do not understand French
- Holder of parental authority opposed to the search
- Minor opposed to search
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
France2 sites, 2 recruiting
- Recruiting
CHU Bourgogne Franche Comté
Besançon
Lauriane VUILLIEZ, 0232888990, cecile.pourcher@chu-rouen.fr
- Recruiting
Chu Rouen
Rouen
Priscille GERARDIN, 0232888990 ext. +33, cecile.pourcher@chu-rouen.fr
About this study
Official title: Etat Des Lieux de la santé Mentale Des Adolescents Suivis Par Les Dispositifs ITEP en France
Assess the prevalence of various psychiatric disorders in adolescents aged 12 to 16 receiving support from therapeutic, educational and pedagogical institutes.
- Conditions
- Mental Health Disorder
- Being tested
- WAIS IV
- Medical subject headings
- Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
WAIS IVDiagnostic test
Psychological assessement
What is being measured
The primary outcome is the main question the study is designed to answer.
Presence of psychiatric disorders
assessed according to DSM-5 by K- SADS-PL
Measured: Inclusion
nature of psychiatric disorders
assessed according to DSM-5 by K- SADS-PL
Measured: Inclusion
Secondary outcomes (14)
Describe the psychological characteristics of adolescents aged 12 to 16
Traumatisms
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Attachement
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Toronto Alexithymia Scale
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Empathy scale
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Impulsivity scale
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Reflective self esteem scale
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Abbreviated-diagnostic interview for borderlines
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Hostility
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Buss Durkee Hostility Inventory
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Mentoring assessed by Reflective Functioning Questionnaire
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Coping strategies assessed by Adolescent Coping Scale
Measured: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Risk behaviour assessed by COLUMBIA-SUICIDE SEVERITY RATING SCALE
Measured: Inclusion
cognitive abilities
Raven's Matrix
Measured: Inclusion
Adverse exepriences
Adverse Child Experiences
Measured: Inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jul 2024
- Study start20 Dec 2024
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental Health DisorderStudies of the same condition, open and under way.
- More trials run by University Hospital, RouenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Rouen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06489912
- Sponsor's protocol ID
- 2022/0282/OB
- Acronym
- PsyPreDi
- Status last verified
- Jun 2026
- First submitted
- 28 Jun 2024
- Last updated
- 10 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Etat Des Lieux de la santé Mentale Des Adolescents Suivis Par Les Dispositifs ITEP en France
- ClinicalTrials.gov ID
- NCT06489912
- Acronym / sponsor ID
- PsyPreDi / 2022/0282/OB
- Conditions
- Mental Health Disorder
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- University Hospital, RouenUniversity, hospital or other
- Study start
- 20 Dec 2024 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 8 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Assess the prevalence of various psychiatric disorders in adolescents aged 12 to 16 receiving support from therapeutic, educational and pedagogical institutes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 12 to 16 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- This is a prospective, multicentric, national cohort, including adolescents aged 12 to 16 consecutively, who have been in a French-speaking, voluntary DITEP for at least 15 days, and whose parents have given their consent. This choice was motivated by the fact that this is the age group most represented in Therapeutic, Educatuional and Pedagogical Institutes
Key inclusion criteria (5 listed)
- Adolescent aged 12 to 16
- In a DITEP for at least 15 days
- Minor who has been informed and has not objected to the research (according to his/her capacity)
- At least one person exercising parental authority who has read and understood the information note and has not objected to the research OR
- For a minor under guardianship: legal representative who has read and understood the information note and has not objected to the research.
Key exclusion criteria (3 listed)
- Minor and/or person(s) exercising parental authority who do not understand French
- Holder of parental authority opposed to the search
- Minor opposed to search
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| WAIS IVPsychological assessement | Diagnostic test | – |
Primary outcome
Presence of psychiatric disorders
Time frame: Inclusion
assessed according to DSM-5 by K- SADS-PL
nature of psychiatric disorders
Time frame: Inclusion
assessed according to DSM-5 by K- SADS-PL
14 secondary outcomes
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16
Time frame: Inclusion
cognitive abilities
Time frame: Inclusion
Adverse exepriences
Time frame: Inclusion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Mental Health Disorder
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Mental Health Disorder, run by University Hospital, Rouen at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Priscille Gerardin, Pr (02.32.88.56.96, priscille.gerardin@chu-roue.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Presence of psychiatric disorders (time frame: Inclusion). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2026.